1. Home
  2. GUTS

as 05-24-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.

Founded: 2010 Country:
United States
United States
Employees: N/A City: BURLINGTON
Market Cap: 338.2M IPO Year: 2024
Target Price: $18.00 AVG Volume (30 days): 297.5K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.43 EPS Growth: N/A
52 Week Low/High: $5.75 - $14.50 Next Earning Date: 05-13-2024
Revenue: $148,000 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks:

Stock Insider Trading Activity of FRACTYL HEALTH INC (GUTS)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Royan Ajay GUTS Director10% Owner Feb 6 '24 Buy $15.00 333,333 $4,999,995.00 1,251,900 SEC Form 4
Elia Marc GUTS Director Feb 6 '24 Buy $15.00 466,666 $6,999,990.00 1,856,117 SEC Form 4
Mithril LP GUTS 10% Owner Feb 6 '24 Buy $15.00 333,333 $4,999,995.00 1,251,900 SEC Form 4
CVF, LLC GUTS 10% Owner Feb 6 '24 Buy $15.00 333,333 $4,999,995.00 4,673,870 SEC Form 4